They then put all this data together and looked for trends in mortality associated with certain treatments for heart disease. And while 42% of participants had ever taken a lipid-lowering therapy of any kind, ongoing use varied by type of therapy. In the end, people who had taken any lipid-lowering therapy in the past year saw their risk of death drop by 41%. And almost all the participants were men; women living with HIV have higher rates of heart attack than their peers. The REPRIEVE study, a randomized controlled trial of statin use in people with HIV, is underway and will provide more information.
At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.